德琪医药-B(06996)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06996 德琪医药-B

交易中 11-19 13:26:34

0.720

-0.020

-2.70%

最高0.760	最低0.660	成交量27.50万
今开0.730	昨收0.740	日振幅13.51%
总市值4.86亿	流通市值4.86亿	总股本6.75亿
成交额19.19万	换手率0.04%	流通股本6.75亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06996","market":"HK","secType":"STK","nameCN":"德琪医药-B","latestPrice":0.72,"timestamp":1731993540176,"preClose":0.74,"halted":0,"volume":275000,"delay":0,"floatShares":674888744,"shares":674888744,"eps":-1.0158312,"marketStatus":"交易中","marketStatusCode":2,"change":-0.02,"latestTime":"11-19 13:26:34","open":0.73,"high":0.76,"low":0.66,"amount":191920,"amplitude":0.135135,"askPrice":0.72,"askSize":45500,"bidPrice":0.69,"bidSize":45000,"shortable":0,"etf":0,"ttmEps":-0.9224632864090514,"exchange":"SEHK","tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1732003800000},"adr":0,"listingDate":1605801600000,"adjPreClose":0.74,"openAndCloseTimeList":[[1731979800000,1731988800000],[1731992400000,1732003200000]],"volumeRatio":1.14932,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06996","defaultTab":"news","newsList":[{"id":"2484795053","title":"德琪医药-B盘中异动 临近午盘大幅下挫5.41%报0.700港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484795053","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484795053?lang=zh_cn&edition=full","pubTime":"2024-11-19 11:59","pubTimestamp":1731988775,"startTime":"0","endTime":"0","summary":"2024年11月19日临近午盘11时59分，德琪医药-B股票出现异动，股价大幅下跌5.41%。截至发稿，该股报0.700港元/股，成交量4.85万股，换手率0.01%，振幅8.11%。资金方面，该股资金流入1110港元，流出1.178万港元。德琪医药-B股票所在的药品行业中，整体跌幅为0.04%。其相关个股中，开拓药业-B、亿胜生物科技、联康生物科技集团涨幅较大，振幅较大的相关个股有联康生物科技集团、德琪医药-B、亿胜生物科技，振幅分别为6.35%、5.41%、5.41%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119115935a244a105&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119115935a244a105&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","06996","BK1191","BK1574"],"gpt_icon":0},{"id":"2484495092","title":"德琪医药－Ｂ(06996)股价下跌5.405%，现价港币$0.7","url":"https://stock-news.laohu8.com/highlight/detail?id=2484495092","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484495092?lang=zh_cn&edition=full","pubTime":"2024-11-19 11:59","pubTimestamp":1731988740,"startTime":"0","endTime":"0","summary":"[下跌股]德琪医药－Ｂ(06996) 股价在上午11:59比前收市价下跌5.405%，现股价为港币$0.7。至目前为止，今日最高价为$0.76，而最低价为$0.7。总成交量为3.85万股，总成交金额为港币$2.714万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150425748_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150425748_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD241119643/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","BK1583","BK1574","06996"],"gpt_icon":0},{"id":"2483194015","title":"德琪医药-B盘中异动 快速下挫5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483194015","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483194015?lang=zh_cn&edition=full","pubTime":"2024-11-13 10:27","pubTimestamp":1731464869,"startTime":"0","endTime":"0","summary":"2024年11月13日早盘10时27分，德琪医药-B股票出现异动，股价大幅下跌5.06%。截至发稿，该股报0.750港元/股，成交量2.15万股，换手率0.00%，振幅5.06%。德琪医药-B股票所在的药品行业中，整体跌幅为0.30%。其相关个股中，泰凌医药、开拓药业-B、中生联合涨幅较大，振幅较大的相关个股有开拓药业-B、康龙化成、艾美疫苗，振幅分别为14.84%、6.13%、5.19%。德琪医药-B公司简介：德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111310275098e423ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111310275098e423ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1191","BK1574","06996"],"gpt_icon":0},{"id":"2480287963","title":"德琪医药-B盘中异动 急速上涨8.43%报0.900港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480287963","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480287963?lang=zh_cn&edition=full","pubTime":"2024-11-04 13:12","pubTimestamp":1730697134,"startTime":"0","endTime":"0","summary":"2024年11月04日下午盘13时12分，德琪医药-B股票出现异动，股价急速拉升8.43%。截至发稿，该股报0.900港元/股，成交量14万股，换手率0.02%，振幅8.43%。资金方面，该股资金流入4.5065万港元，流出5.0565万港元。德琪医药-B股票所在的药品行业中，整体涨幅为0.42%。其相关个股中，信达生物、中生联合、海王英特龙涨幅较大，振幅较大的相关个股有顺腾国际控股、兴科蓉医药、凯莱英，振幅分别为13.89%、8.33%、8.01%。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104131214a213661e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104131214a213661e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06996","BK1583","BK1574","BK1191"],"gpt_icon":0},{"id":"2480027494","title":"德琪医药-B盘中异动 临近收盘大幅下挫5.62%报0.840港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480027494","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480027494?lang=zh_cn&edition=full","pubTime":"2024-11-01 15:30","pubTimestamp":1730446255,"startTime":"0","endTime":"0","summary":"2024年11月01日临近收盘15时30分，德琪医药-B股票出现波动，股价快速跳水5.62%。截至发稿，该股报0.840港元/股，成交量32.05万股，换手率0.05%，振幅12.36%。德琪医药-B股票所在的药品行业中，整体涨幅为0.08%。其相关个股中，顺腾国际控股、艾美疫苗、李氏大药厂涨幅较大，振幅较大的相关个股有顺腾国际控股、中生联合、德琪医药-B，振幅分别为88.89%、12.90%、12.36%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101153059ab90b76c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101153059ab90b76c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06996","BK1574","BK1583","BK1191"],"gpt_icon":0},{"id":"2479717276","title":"德琪医药-B盘中异动 早盘快速上涨8.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479717276","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479717276?lang=zh_cn&edition=full","pubTime":"2024-10-31 10:58","pubTimestamp":1730343488,"startTime":"0","endTime":"0","summary":"2024年10月31日早盘10时58分，德琪医药-B股票出现波动，股价急速上涨8.54%。德琪医药-B股票所在的药品行业中，整体跌幅为0.14%。其相关个股中，顺腾国际控股、中生联合、长江生命科技涨幅较大，振幅较大的相关个股有长江生命科技、艾美疫苗、开拓药业-B，振幅分别为7.95%、6.77%、6.14%。德琪医药-B公司简介：德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031105808ab87f631&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031105808ab87f631&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06996","BK1583","BK1191","BK1574"],"gpt_icon":0},{"id":"2479216883","title":"德琪医药-B盘中异动 股价大涨5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479216883","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479216883?lang=zh_cn&edition=full","pubTime":"2024-10-30 10:52","pubTimestamp":1730256731,"startTime":"0","endTime":"0","summary":"2024年10月30日早盘10时52分，德琪医药-B股票出现异动，股价急速拉升5.88%。截至发稿，该股报0.900港元/股，成交量1.1万股，换手率0.00%，振幅5.88%。德琪医药-B股票所在的药品行业中，整体跌幅为0.30%。其相关个股中，泰凌医药、复星医药、白花油涨幅较大，振幅较大的相关个股有艾美疫苗、翰森制药、康龙化成，振幅分别为9.19%、7.43%、6.57%。德琪医药-B公司简介：德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030105211ab80ae03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030105211ab80ae03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1191","06996","BK1583"],"gpt_icon":0},{"id":"2479844903","title":"德琪医药-B盘中异动 下午盘快速下挫5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479844903","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479844903?lang=zh_cn&edition=full","pubTime":"2024-10-29 14:18","pubTimestamp":1730182716,"startTime":"0","endTime":"0","summary":"2024年10月29日下午盘14时18分，德琪医药-B股票出现波动，股价快速跳水5.62%。德琪医药-B股票所在的药品行业中，整体跌幅为0.27%。其相关个股中，四环医药、三爱健康集团、开拓药业-B涨幅较大，振幅较大的相关个股有四环医药、三爱健康集团、信达生物，振幅分别为23.94%、11.29%、9.82%。德琪医药-B公司简介：德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102914183698e3f05b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102914183698e3f05b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1574","06996","BK1583"],"gpt_icon":0},{"id":"2478624521","title":"德琪医药-B盘中异动 下午盘急速拉升7.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478624521","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478624521?lang=zh_cn&edition=full","pubTime":"2024-10-25 13:40","pubTimestamp":1729834843,"startTime":"0","endTime":"0","summary":"2024年10月25日下午盘13时40分，德琪医药-B股票出现异动，股价急速上涨7.41%。德琪医药-B股票所在的药品行业中，整体涨幅为0.33%。其相关个股中，泰凌医药、康龙化成、凯莱英涨幅较大，振幅较大的相关个股有泰凌医药、顺腾国际控股、君圣泰医药-B，振幅分别为58.73%、14.63%、10.81%。德琪医药-B公司简介：德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102513404398e3e6fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102513404398e3e6fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06996","BK1574","BK1191","BK1583"],"gpt_icon":0},{"id":"2478628511","title":"德琪医药－Ｂ(06996)股价上升6.173%，现价港币$0.86","url":"https://stock-news.laohu8.com/highlight/detail?id=2478628511","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478628511?lang=zh_cn&edition=full","pubTime":"2024-10-25 11:44","pubTimestamp":1729827840,"startTime":"0","endTime":"0","summary":"[上升股]德琪医药－Ｂ(06996) 股价在上午11:44比前收市价上升6.173%，现股价为港币$0.86。至目前为止，今日最高价为$0.86，而最低价为$0.8。总成交量为28.4万股，总成交金额为港币$23.691万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2410252142/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","06996","BK1583","BK1191"],"gpt_icon":0},{"id":"2476641646","title":"德琪医药-B盘中异动 大幅上涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476641646","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476641646?lang=zh_cn&edition=full","pubTime":"2024-10-18 10:42","pubTimestamp":1729219327,"startTime":"0","endTime":"0","summary":"2024年10月18日早盘10时42分，德琪医药-B股票出现异动，股价快速拉升5.13%。德琪医药-B股票所在的药品行业中，整体涨幅为0.28%。其相关个股中，华控康泰、康龙化成、四环医药涨幅较大，振幅较大的相关个股有艾美疫苗、泰凌医药、康龙化成，振幅分别为9.21%、9.21%、6.07%。德琪医药-B公司简介：德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018104207971a0f82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018104207971a0f82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1191","06996","BK1574"],"gpt_icon":0},{"id":"2476549559","title":"德琪医药(06996)：希维奥第3项适应症新药补充上市申请获韩国批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2476549559","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476549559?lang=zh_cn&edition=full","pubTime":"2024-10-18 08:57","pubTimestamp":1729213079,"startTime":"0","endTime":"0","summary":"金吾财讯 | 德琪医药(06996)公布，韩国食品药品安全部(MFDS)已批准希维奥(塞利尼索片)与硼替佐米和地塞米松联用，用于治疗既往接受过至少一种治疗的多发性骨髓瘤(MM)成年患者的新药补充上市申请(sNDA)。希维奥是世界首款获批准的核输出蛋白口服选择性XPO1抑制剂。其具有新颖的作用机制，在联合治疗中具有协同作用，快速起效，且反应持久。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/ZGJmMjQzMjRiY2NiODcyOGI4M2QwNmEzMTRlMzQwNzE0NzI4MDg4Ng==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZGJmMjQzMjRiY2NiODcyOGI4M2QwNmEzMTRlMzQwNzE0NzI4MDg4Ng==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1946057","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996","BK1574","BK1191","BK1583"],"gpt_icon":0},{"id":"2476498535","title":"德琪医药-B获批新适应症药物上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2476498535","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476498535?lang=zh_cn&edition=full","pubTime":"2024-10-18 08:23","pubTimestamp":1729211006,"startTime":"0","endTime":"0","summary":"财中社10月18日电德琪医药-B（06996）发布公告，韩国食品药品安全部已批准其新药希维奥?（塞利尼索片）用于治疗既往接受过至少一种治疗的多发性骨髓瘤成年患者的补充上市申请。这一批准标志着希维奥?在新适应症的商业化进程迈出了重要一步。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202410183209623837.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06996","BK1574","BK1583","BK1191"],"gpt_icon":0},{"id":"2476946098","title":"德琪医药(06996.HK)治疗多发性骨髓瘤新药补充上市申请获韩国批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2476946098","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476946098?lang=zh_cn&edition=full","pubTime":"2024-10-18 08:23","pubTimestamp":1729210980,"startTime":"0","endTime":"0","summary":"德琪医药(06996.HK) 公布，韩国食品药品安全部(MFDS)已批准希维奥(塞利尼索片)与硼替佐米和地塞米松联用，用于治疗既往接受过至少一种治疗的多发性骨髓瘤(MM)成年患者的新药补充上市申请(sNDA)。希维奥是世界首款获批准的核输出蛋白口服选择性XPO1抑制剂。其具有新颖的作用机制，在联合治疗中具有协同作用，快速起效，且反应持久。(jl/w)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210304121502059_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210304121502059_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1389179/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1583","BK1191","BK1574","06996"],"gpt_icon":0},{"id":"2476461153","title":"德琪医药-B：希维奥®第三项适应症的新药补充上市申请获韩国食品药品安全部批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2476461153","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476461153?lang=zh_cn&edition=full","pubTime":"2024-10-18 07:47","pubTimestamp":1729208820,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　德琪医药-B（06996）发布公告，韩国食品药品安全部（MFDS）已批准希维奥® （塞利尼索片）与硼替佐米和地塞米松联用，用于治疗既往接受过至少一种治疗的多发性骨髓瘤（MM）成年患者的新药补充上市申请（sNDA）。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-10-18/doc-incsxqvc8850987.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-10-18/doc-incsxqvc8850987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1191","06996","BK1583","BK1574"],"gpt_icon":0},{"id":"2476846850","title":"德琪医药-B(06996)：希维奥®第三项适应症的新药补充上市申请获韩国食品药品安全部批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2476846850","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476846850?lang=zh_cn&edition=full","pubTime":"2024-10-18 06:50","pubTimestamp":1729205401,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德琪医药-B(06996)发布公告，韩国食品药品安全部(MFDS)已批准希维奥® (塞利尼索片)与硼替佐米和地塞米松联用，用于治疗既往接受过至少一种治疗的多发性骨髓瘤(MM)成年患者的新药补充上市申请(sNDA)。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1195643.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1583","06996","BK1574","BK1191"],"gpt_icon":0},{"id":"2476136299","title":"德琪医药-B盘中异动 早盘快速上涨6.49%报0.820港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476136299","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476136299?lang=zh_cn&edition=full","pubTime":"2024-10-17 10:25","pubTimestamp":1729131958,"startTime":"0","endTime":"0","summary":"2024年10月17日早盘10时25分，德琪医药-B股票出现异动，股价急速上涨6.49%。截至发稿，该股报0.820港元/股，成交量5000股，换手率0.00%，振幅6.49%。德琪医药-B股票所在的药品行业中，整体涨幅为0.61%。德琪医药-B公司简介：德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017102558971a0c06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017102558971a0c06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06996","BK1574","BK1583","BK1191"],"gpt_icon":0},{"id":"2475625800","title":"德琪医药-B盘中异动 股价大跌7.41%报0.750港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475625800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475625800?lang=zh_cn&edition=full","pubTime":"2024-10-16 09:30","pubTimestamp":1729042221,"startTime":"0","endTime":"0","summary":"2024年10月16日早盘09时30分，德琪医药-B股票出现异动，股价大幅跳水7.41%。截至发稿，该股报0.750港元/股，成交量2万股，换手率0.00%，振幅7.41%。资金方面，该股资金流入0港元，流出6000港元。德琪医药-B股票所在的药品行业中，整体跌幅为0.09%。其相关个股中，石四药集团、开拓药业-B、丽珠医药涨幅较大，振幅较大的相关个股有凯莱英、德琪医药-B、翰森制药，振幅分别为8.76%、7.41%、2.91%。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016093021971a07cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016093021971a07cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1574","06996","BK1583"],"gpt_icon":0},{"id":"2475555595","title":"德琪医药-B盘中异动 下午盘快速下挫5.81%报0.810港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475555595","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475555595?lang=zh_cn&edition=full","pubTime":"2024-10-15 13:25","pubTimestamp":1728969935,"startTime":"0","endTime":"0","summary":"2024年10月15日下午盘13时25分，德琪医药-B股票出现异动，股价急速下挫5.81%。截至发稿，该股报0.810港元/股，成交量23.9万股，换手率0.04%，振幅8.14%。资金方面，该股资金流入2.9495万港元，流出16.0075万港元。德琪医药-B股票所在的药品行业中，整体跌幅为0.15%。其相关个股中，康臣药业、海王英特龙、翰森制药涨幅较大，振幅较大的相关个股有华控康泰、泰凌医药、中生联合，振幅分别为25.00%、11.58%、11.48%。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015132535a1e0b89a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241015132535a1e0b89a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06996","BK1574","BK1191","BK1583"],"gpt_icon":0},{"id":"2475806959","title":"德琪医药-B盘中异动 早盘股价大跌5.38%报0.880港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475806959","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475806959?lang=zh_cn&edition=full","pubTime":"2024-10-14 09:51","pubTimestamp":1728870671,"startTime":"0","endTime":"0","summary":"2024年10月14日早盘09时51分，德琪医药-B股票出现异动，股价急速跳水5.38%。截至发稿，该股报0.880港元/股，成交量5.25万股，换手率0.01%，振幅5.38%。资金方面，该股资金流入0港元，流出3.62万港元。德琪医药-B股票所在的药品行业中，整体跌幅为0.43%。其相关个股中，精优药业、泰凌医药、长江生命科技涨幅较大，振幅较大的相关个股有三爱健康集团、精优药业、泰凌医药，振幅分别为15.71%、12.50%、11.70%。该公司主要在亚太地区开展业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014095111a1e06318&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014095111a1e06318&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06996","BK1574","BK1583","BK1191"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.antengene.com","stockEarnings":[{"period":"1week","weight":-0.0976},{"period":"1month","weight":-0.1294},{"period":"3month","weight":0.3455},{"period":"6month","weight":-0.2745},{"period":"1year","weight":-0.5375},{"period":"ytd","weight":-0.63}],"compareEarnings":[{"period":"1week","weight":-0.0416},{"period":"1month","weight":-0.059},{"period":"3month","weight":0.118},{"period":"6month","weight":0.0198},{"period":"1year","weight":0.1216},{"period":"ytd","weight":0.1484}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"德琪医药有限公司是一家专注于创新抗肿瘤药物的亚太地区临床阶段生物制药公司。该公司主要从事生物科技产品的发现、开发、生产及商业化。该公司的主要产品包括用于治疗复发╱难治性多发性骨髓瘤、复发╱难治性弥漫大B细胞淋巴瘤和非小细胞肺癌的ATG-010(selinexor)及用于治疗肝细胞癌和非小细胞肺癌等多种适应症的ATG-008(onatasertib)。该公司主要在亚太地区开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.154186},{"month":2,"riseRate":0,"avgChangeRate":-0.104806},{"month":3,"riseRate":0.25,"avgChangeRate":-0.090913},{"month":4,"riseRate":0.5,"avgChangeRate":-0.02339},{"month":5,"riseRate":0.5,"avgChangeRate":-0.047362},{"month":6,"riseRate":0.25,"avgChangeRate":-0.063163},{"month":7,"riseRate":0,"avgChangeRate":-0.201302},{"month":8,"riseRate":0.25,"avgChangeRate":-0.091947},{"month":9,"riseRate":0.25,"avgChangeRate":-0.038884},{"month":10,"riseRate":0.5,"avgChangeRate":0.098032},{"month":11,"riseRate":0.75,"avgChangeRate":0.121553},{"month":12,"riseRate":0.5,"avgChangeRate":0.044026}],"exchange":"SEHK","name":"德琪医药-B","nameEN":"ANTENGENE-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"德琪医药-B(06996)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供德琪医药-B(06996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"德琪医药-B,06996,德琪医药-B股票,德琪医药-B股票老虎,德琪医药-B股票老虎国际,德琪医药-B行情,德琪医药-B股票行情,德琪医药-B股价,德琪医药-B股市,德琪医药-B股票价格,德琪医药-B股票交易,德琪医药-B股票购买,德琪医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"德琪医药-B(06996)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供德琪医药-B(06996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}